{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:51:14Z","timestamp":1789203074429,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lfs.2021.120001","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T12:28:36Z","timestamp":1633350516000},"page":"120001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Effects of low-dose insulin or a soluble guanylate cyclase activator on lower urinary tract dysfunction in streptozotocin-induced diabetic rats"],"prefix":"10.1016","volume":"286","author":[{"given":"Daisuke","family":"Gotoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo C.","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Morizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunta","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"109\u201342","key":"10.1016\/j.lfs.2021.120001_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2021.120001_bb0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(25)00442-9","article-title":"Pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Anderson","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2021.120001_bb0015","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/01.ju.0000121283.92963.05","article-title":"Urethral dysfunction in diabetic rats","volume":"171","author":"Torimoto","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.lfs.2021.120001_bb0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/nau.23372","article-title":"Tadalafil, a phosphodiesterase type 5 inhibitor, improves bladder blood supply and restores the initial phase of lower urinary tract dysfunction in diabetic rats","volume":"37","author":"Gotoh","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.lfs.2021.120001_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117537","article-title":"Urethral dysfunction and alterations of nitric oxide mechanisms in streptozotocin-induced diabetic rats with or without low-dose insulin treatment","volume":"249","author":"Cao","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.120001_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156346","article-title":"Short- and longterm glycemic control of streptozotocin-induced diabetic rats using different insulin preparations","volume":"11","author":"Luippold","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.120001_bb0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.113.211029","article-title":"Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60\u20132770","volume":"349","author":"Alexandre","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2021.120001_bb0040","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lfs.2013.03.021","article-title":"Effect of naftopidil, an alpha1D\/A-adrenoceptor antagonist, on the urinary bladder in rats with spinal cord injury","volume":"92","author":"Kadekawa","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.120001_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/luts.12272","article-title":"Tadalafil, a phosphodiesterase type 5 inhibitor, restores urethra and detrusor function in the initial phase of diabetes in rats","volume":"11","author":"Gotoh","year":"2019","journal-title":"Low Urin. Tract. Symptoms"},{"key":"10.1016\/j.lfs.2021.120001_bb0050","doi-asserted-by":"crossref","first-page":"R752","DOI":"10.1152\/ajpregu.00450.2015","article-title":"Characterization of bladder and external urethral activity in mice with or without spinal cord injury\u2013a comparison study with rats","volume":"310","author":"Kadekawa","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.lfs.2021.120001_bb0055","doi-asserted-by":"crossref","first-page":"F754","DOI":"10.1152\/ajprenal.00566.2019","article-title":"Urethral dysfunction in a rat model of chemically induced prostatic inflammation: potential involvement of the MRP5 pump","volume":"318","author":"Alexandre","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.lfs.2021.120001_bb0060","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/nau.23158","article-title":"Effects of an alpha1A\/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury","volume":"36","author":"Kadekawa","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.lfs.2021.120001_bb0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/nau.23066","article-title":"Combinational effects of muscarinic receptor inhibition and beta3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury","volume":"36","author":"Wada","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.lfs.2021.120001_bb0070","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.juro.2009.07.084","article-title":"Animal models of diabetic uropathy","volume":"182","author":"Daneshgari","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.lfs.2021.120001_bb0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.ju.0000146268.45662.36","article-title":"Alpha1-adrenergic mechanism in diabetic urethral dysfunction in rats","volume":"173","author":"Torimoto","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.lfs.2021.120001_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/nau.22517","article-title":"Functional consequences of chronic bladder ischemia","volume":"33","author":"Yamaguchi","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.lfs.2021.120001_bb0085","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2011","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.lfs.2021.120001_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrurol.2017.181","article-title":"Stimulators and activators of soluble guanylate cyclase for urogenital disorders","volume":"15","author":"Monica","year":"2018","journal-title":"Nat.Rev. Urol."},{"key":"10.1016\/j.lfs.2021.120001_bb0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2220\/biomedres.30.331","article-title":"Long-term effects of diabetes mellitus on voiding function in a new model of type 2 diabetes mellitus, the spontaneously diabetic torii (SDT) rat","volume":"30","author":"Matsumoto","year":"2009","journal-title":"Biomed. Res."},{"key":"10.1016\/j.lfs.2021.120001_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.juro.2012.10.060","article-title":"Characteristics of lower urinary tract dysfunction and bladder afferent nerve properties in type 2 diabetic goto-kakizaki rats","volume":"189","author":"Aizawa","year":"2013","journal-title":"J. Urol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521009887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521009887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:49:56Z","timestamp":1758401396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521009887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":20,"alternative-id":["S0024320521009887"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120001","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of low-dose insulin or a soluble guanylate cyclase activator on lower urinary tract dysfunction in streptozotocin-induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120001"}}